At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 12 enrolled
Drug / intervention
The Resonator +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-blind, Sham-stimulation Controlled Study of the Application of Magnetic Fields Using the Jacobson Resonator for the Treatment of Parkinson's Disease.
In Brief
A Phase 2 clinical trial evaluating The Resonator and The Resonator control for Parkinson's Disease. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if low level magnetic fields may help to relieve symptoms of Parkinson's disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson's Disease
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2007
First PostedOct 2008
Primary CompletionJun 2009
TodayJul 2026
First PostedOct 24, 2008
Enrollment StartAug 1, 2007
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 17.7 years ago
Interventions
The Resonatordevice
active magnetic field therapy
The Resonator controldevice
inactive magnetic field therapy with placebo fields